Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome

S Franik, SM Eltrop, JAM Kremer… - Cochrane Database …, 2018 - cochranelibrary.com
Background Polycystic ovary syndrome (PCOS) is the most common cause of infrequent
periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 4% to …

Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome

S Franik, QK Le, JAM Kremer, L Kiesel… - Cochrane Database …, 2022 - cochranelibrary.com
Background Polycystic ovary syndrome (PCOS) is the most common cause of infrequent
periods (oligomenorrhoea) and absence of periods (amenorrhoea). It affects about 5% to …

Comparison of clomiphene citrate and letrozole for ovulation induction in women with polycystic ovary syndrome: a prospective randomized trial

C Liu, G Feng, W Huang, Q Wang, S Yang… - Gynecological …, 2017 - Taylor & Francis
To compare the therapeutic efficacy of clomiphene citrate (CC) and letrozole (LE) on
ovulation, pregnancy, and live birth in women with polycystic ovary syndrome (PCOS); and …

[HTML][HTML] Clomiphene citrate versus letrozole with gonadotropins in intrauterine insemination cycles: A randomized trial

L Pourali, S Ayati, S Tavakolizadeh… - International Journal …, 2017 - ncbi.nlm.nih.gov
Background: Clomiphene citrate is one of the effective drugs for infertility treatment due to
oligo-ovulation or anovulation. Intrauterine insemination (IUI) is one of more adherent …

Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian …

A Bjelica, A Trninić-Pjević… - Srpski arhiv za …, 2016 - doiserbia.nb.rs
Introduction. Polycystic ovary syndrome is the most common endocrinopathy in women of
reproductiveage. Therapy for those who want to get pregnant involves ovulation induction …

The future of frozen-thawed embryo transfer in hormone replacement therapy cycles

K Løssl, AL Spangmose, LL Asserhøj… - Current Opinion in …, 2023 - journals.lww.com
Natural and modified NC FET should be used whenever possible to mitigate adverse
obstetric and perinatal outcomes after HRT FET. For anovulatory women, whenever …

[PDF][PDF] Comparing effectiveness of letrozole versus clomiphene citrate to evaluate the ovulation induction in patients with polycystic ovarian syndrome

T ZAFAR, F ASIF, R NAURIN, T MAJEED… - Age (years), 2021 - pjmhsonline.com
Background: Anovulation is the commonest cause of female infertility and polycystic ovarian
syndrome (PCOS) is the most frequently seen cause of anovulation among infertile females …

Therapeutic impact of letrozole and clomiphene citrate for ovulation induction in Iraqi female patients with polycystic ovary syndrome

HD Najim, WS Al-Khfajy, Z Albasry… - International Journal of …, 2023 - journals.lww.com
Materials and Methods: A prospective, randomized, controlled study was carried out on 166
female patients diagnosed with anovulatory infertility due to PCOS and randomly assigned …

[PDF][PDF] Endometrial thinning after ovarian stimulation using letrozole or clomiphene citrate: A randomized trial

R Choavaratana, K Malakorn… - Siriraj Medical …, 2018 - researchgate.net
Objective: To compare endometrial thickness after three consecutive cycles of ovulation
induction with clomiphene citrate versus letrozole. Methods: Eighty-four women with normal …

A randomized trial of combined letrozole with metformin versus clomiphene citrate with metformin in polycystic ovary (PCOS) patients

F El Omda, A Abd El Fattah, M Hashish… - The Egyptian Journal of …, 2018 - journals.ekb.eg
Background: Polycystic Ovary Syndrome (PCOS) is one of the most common causes of
anovulatory infertility. Currently, clomiphene citrate (CC) is considered the first-line therapy …